These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5771580)

  • 1. Action of a pyrimido-pyrimidine compound on platelet behaviour in vitro.
    Forbes CD; McNicol GP; Douglas AS
    Br Med J; 1969 May; 2(5655):483-5. PubMed ID: 5771580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of RA233 on platelet function in vitro.
    Hassanein AA; Turpie AG; McNicol GP; Douglas AS
    Br Med J; 1970 Apr; 2(5701):83-6. PubMed ID: 5420238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dipyridamole and two pyrimido-pyrimidine derivatives on the kinetics of human platelet aggregation and on platelet adhesiveness.
    Eliasson R; Bygdeman S
    Scand J Clin Lab Invest; 1969 Sep; 24(2):145-51. PubMed ID: 5383322
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pyrimido-pyrimidine compounds on platelet function.
    Cucuianu MP; Nishizawa EE; Mustard JF
    J Lab Clin Med; 1971 Jun; 77(6):958-74. PubMed ID: 5559863
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction. Action of pyrimido-pyrimidine compounds on platelet behaviour in vitro.
    Douglas AS
    Acta Med Scand Suppl; 1971; 525():231-5. PubMed ID: 5292095
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines.
    Slater SD; Turpie AG; Douglas AS; McNicol GP
    J Clin Pathol; 1972 May; 25(5):427-32. PubMed ID: 5046075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a pyrimido-pyrimidine compound on platelet behaviour in vitro and in vivo.
    Elkeles RS; Hampton JR; Honour AJ; Mitchell JR; Prichard JS
    Lancet; 1968 Oct; 2(7571):751-4. PubMed ID: 4175551
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviour.
    Hampton JR; Harrison MJ; Honour AJ; Mitchell JR; Prichard JS
    Cardiovasc Res; 1972 Nov; 6(6):696-701. PubMed ID: 4656476
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of dipyridamole on human platelet behaviour.
    Emmons PR; Harrison MJ; Honour AJ; Mitchell JR
    Lancet; 1965 Sep; 2(7413):603-6. PubMed ID: 4157500
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets.
    Rozenberg MC; Walker CM
    Br J Haematol; 1973 Apr; 24(4):409-18. PubMed ID: 4351761
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of some pyrimido-pyrimidine derivatives on blood coagulation and platelet aggregation.
    Bédi J; Blaskó G; Pálos LA
    Arzneimittelforschung; 1979; 29(9):1405-8. PubMed ID: 583250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of dipyridamole and adenosine on platelet aggregation.
    Philp RB; Lemieux JP
    Nature; 1969 Mar; 221(5186):1162-4. PubMed ID: 4975285
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of platelet retention in glass bead columns to the rate of aggregation with adenosine diphosphate and thrombin.
    Bloom AL; Evans EP
    J Clin Pathol; 1969 Sep; 22(5):560-2. PubMed ID: 5364441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of the cancer stickiness by pyrimido-pyrimidine derivates induced by inhibition of platelet aggregation.
    Gastpar H
    Acta Med Scand Suppl; 1971; 525():269-71. PubMed ID: 5292100
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of dipyridamole on platelet function: correlation with blood levels in man.
    Rajah SM; Crow MJ; Penny AF; Ahmad R; Watson DA
    Br J Clin Pharmacol; 1977 Apr; 4(2):129-33. PubMed ID: 861128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets, thrombosis and drugs.
    Mustard JF; Packham MA
    Drugs; 1975; 9(1):19-76. PubMed ID: 1092540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3-diphosphoglycerate: a physiological inhibitor of platelet aggregation.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Science; 1975 Jan; 187(4173):259-61. PubMed ID: 1111100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dipyridamole and RA 233 on human platelet function in vitro.
    Rifkin PL; Zucker MB
    Thromb Diath Haemorrh; 1973 Jun; 29(3):694-700. PubMed ID: 4761835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.